{
    "2021-03-01": [
        [
            {
                "time": "",
                "original_text": "沃森生物：公司新冠mRNA疫苗的临床试验在正常推进中",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新冠",
                        "mRNA疫苗",
                        "临床试验",
                        "正常推进"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)获得1项发明专利证书",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "发明专利",
                        "证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}